Gene Salkind - 28 Oct 2022 Form 3 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Gene Salkind
Issuer symbol
COEP
Transactions as of
28 Oct 2022
Net transactions value
$0
Form type
3
Filing time
07 Nov 2022, 13:00:24 UTC
Previous filing
17 Nov 2022
Next filing
31 Jan 2023

No securities are beneficially owned.